195 related articles for article (PubMed ID: 27881608)
1. Genetics of Diabetic Kidney Disease-From the Worst of Nightmares to the Light of Dawn?
Ma RC; Cooper ME
J Am Soc Nephrol; 2017 Feb; 28(2):389-393. PubMed ID: 27881608
[No Abstract] [Full Text] [Related]
2. Biologic Underpinnings of Type 1 Diabetic Kidney Disease.
Sedor JR; Freedman BI
J Am Soc Nephrol; 2019 Oct; 30(10):1782-1783. PubMed ID: 31570541
[No Abstract] [Full Text] [Related]
3. Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease.
Cherney DZ; Tuttle KR
Clin J Am Soc Nephrol; 2020 Apr; 15(4):444-446. PubMed ID: 32149722
[No Abstract] [Full Text] [Related]
4. Kidney biopsy findings in children with diabetes mellitus.
Weerasooriya L; Howie AJ; Wakeman MP; Cavanagh S; Milford DV
Pediatr Nephrol; 2024 Jun; 39(6):1865-1873. PubMed ID: 38123711
[TBL] [Abstract][Full Text] [Related]
5. Non-Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus-11-Year Experience from a Single Center.
Grujicic M; Salapura A; Basta-Jovanovic G; Figurek A; Micic-Zrnic D; Grbic A
Med Arch; 2019 Apr; 73(2):87-91. PubMed ID: 31391693
[TBL] [Abstract][Full Text] [Related]
6. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Diabetic Kidney Disease.
Florez JC
Semin Nephrol; 2016 Nov; 36(6):474-480. PubMed ID: 27987549
[No Abstract] [Full Text] [Related]
8. Is clinical trial data showing positive progress for the treatment of diabetic kidney disease?
Tan SK; Cooper ME
Expert Opin Emerg Drugs; 2023 Dec; 28(4):217-226. PubMed ID: 37897430
[No Abstract] [Full Text] [Related]
9. Advances in early biomarkers of diabetic nephropathy.
Zhang J; Liu J; Qin X
Rev Assoc Med Bras (1992); 2018 Jan; 64(1):85-92. PubMed ID: 29561946
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).
Raman R; Gupta A; Krishna S; Kulothungan V; Sharma T
J Diabetes Complications; 2012; 26(2):123-8. PubMed ID: 22446033
[TBL] [Abstract][Full Text] [Related]
11. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Diagnosis, prevention and treatment in diabetic nephropathy.
Rando MM; Guthoff M; Tiwari V; Biscetti F
Front Endocrinol (Lausanne); 2022; 13():1011665. PubMed ID: 36120444
[No Abstract] [Full Text] [Related]
13. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
[TBL] [Abstract][Full Text] [Related]
14. Synopsis of Sweet! Mouse Models of Diabetic Kidney Disease.
Heinz-Taheny KM; Harlan SM; Qi Z; Heuer JG
Toxicol Pathol; 2018 Dec; 46(8):970-975. PubMed ID: 30213245
[TBL] [Abstract][Full Text] [Related]
15. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic nephropathy].
Weekers L; Krzesinski JM
Rev Med Liege; 2005; 60(5-6):479-86. PubMed ID: 16041860
[TBL] [Abstract][Full Text] [Related]
17. Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy.
Takahashi K; Yamamoto H; Hirose T; Hiraishi K; Shoji I; Shibasaki A; Kato I; Kaneko K; Sasano H; Satoh F; Totsune K
Peptides; 2010 Jul; 31(7):1405-8. PubMed ID: 20385187
[TBL] [Abstract][Full Text] [Related]
18. The study of association of Vitamin B
Bherwani S; Ahirwar AK; Saumya AS; Sandhya AS; Prajapat B; Patel S; Jibhkate SB; Singh R; Ghotekar LH
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S365-S368. PubMed ID: 28283394
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
Conserva F; Pontrelli P; Accetturo M; Gesualdo L
J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
[TBL] [Abstract][Full Text] [Related]
20. Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.
Prakash J; Patel PS; Iqbal M; Sharma SS; Singh S; Agrawal NK; Singh U
J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
